|
|||||
|
|
Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome |
|
| Authors: | Betül Oran MD Rima M. Saliba PhD Rohtesh S. Mehta MD MPH MS Amin M. Alousi MD David Marin MD Ben C. Valdez PhD Julianne Chen BS Qaiser Bashir MD Stefan O. Ciurea MD Amanda L. Olson MD Chitra Hosing MD Partow Kebriaei MD Katy Rezvani MD PhD Elizabeth J. Shpall MD Richard E. Champlin MD Borje S. Andersson MD PhD Uday R. Popat MD MBA |
| Affiliation: | Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| Abstract: | |
| Keywords: | acute myeloid leukemia (AML) busulfan fractionated myeloablative myelodysplastic syndrome (MDS) |